Alzheimer's disease: cardiovascular risk factors must be assessed

被引:6
作者
Antoine, V
Rigaud, AS
机构
[1] CHI Poissy Maisonnees, Consultat Memoire, F-78300 Poissy, France
[2] Hop Broca, Serv Geriatrie, F-75013 Paris, France
来源
REVUE DE MEDECINE INTERNE | 2006年 / 27卷 / 01期
关键词
elderly; Alzheimer's disease; vascular dementia; vascular risk factors;
D O I
10.1016/j.revmed.2005.04.037
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. - Dementia is nowadays of major importance in public health. Alzheimer's disease and vascular cognitive impairments are its main aetiology in the elderly. The cause of Alzheimer's disease remains unknown. The factor initiating the physiopathology of this neurodegenerative disease is source of controversy. Current knowledge and key points. - The theory of a neurotoxicity initiated by amyloid deposition is questioned. A growing number of data suggest a central role of cardiovascular risk factors and alteration of arterial walls, inducing chronic brain hypoperfusion, as the primary trigger in the physiopathology of the disease. These data are based on epidemiological, physiopathological, neuroimaging, neuropathological and pharmacological studies. However, the exact link between arteriosclerosis, vascular cognitive impairment and Alzheimer's disease remains controversial. Future prospects and projects. - These debates point out the crucial importance of the assessment of cardiovascular risk factors, as a preventable cause, either of cognitive decline, morbidity and mortality. In this aim, major targets could be different when primary or secondary prevention are at stake. These controversies also suggest new research directions towards Alzheimer's disease physiopathology, and for pharmacological interventions aimed on the prevention of cognitive decline or the curative treatment for this disease. (C) 2005 Elsevier SAS. Tous droits reserves.
引用
收藏
页码:21 / 31
页数:11
相关论文
共 50 条
  • [21] The Links between Cardiovascular Diseases and Alzheimer's Disease
    Leszek, Jerzy
    Mikhaylenko, Elizaveta, V
    Belousov, Dmitrii M.
    Koutsouraki, Efrosini
    Szczechowiak, Katarzyna
    Kobusiak-Prokopowicz, Malgorzata
    Mysiak, Andrzej
    Diniz, Breno Satler
    Somasundaram, Siva G.
    Kirkland, Cecil E.
    Aliev, Gjumrakch
    CURRENT NEUROPHARMACOLOGY, 2021, 19 (02) : 152 - 169
  • [22] Vascular risk factors in Alzheimer's disease - Preliminary report
    Stefanova, E.
    Pavlovic, A.
    Jovanovic, Z.
    Veselinovic, N.
    Despotovic, I.
    Stojkovic, T.
    Sternic, N.
    Kostic, V.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2012, 322 (1-2) : 166 - 169
  • [23] Military risk factors for Alzheimer's disease
    Weiner, Michael W.
    Friedl, Karl E.
    Pacifico, Anthony
    Chapman, Julie C.
    Jaffee, Michael S.
    Little, Deborah M.
    Manley, Geoffrey T.
    McKee, Ann
    Petersen, Ronald C.
    Pitman, Roger K.
    Yaffe, Kristine
    Zetterberg, Henrik
    Obana, Robert
    Bain, Lisa J.
    Carrillo, Maria C.
    ALZHEIMERS & DEMENTIA, 2013, 9 (04) : 445 - 451
  • [24] Alzheimer's disease - Genetic and risk factors
    Novak, M
    CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 1996, 59 (05): : 245 - 253
  • [25] Modifiable Risk Factors for Alzheimer's Disease
    Edwards, George A., III
    Gamez, Nazaret
    Escobedo, Gabriel, Jr.
    Calderon, Olivia
    Moreno-Gonzalez, Ines
    FRONTIERS IN AGING NEUROSCIENCE, 2019, 11
  • [26] Vascular risk factors and Alzheimer's disease
    O'Brien, John T.
    Markus, Hugh S.
    BMC MEDICINE, 2014, 12
  • [27] Apolipoprotein E, cholesterol metabolism, diabetes, and the convergence of risk factors for Alzheimer's disease and cardiovascular disease
    Martins, I. J.
    Hone, E.
    Foster, J. K.
    Sunram-Lea, S. I.
    Gnjec, A.
    Fuller, S. J.
    Nolan, D.
    Gandy, S. E.
    Martins, R. N.
    MOLECULAR PSYCHIATRY, 2006, 11 (08) : 721 - 736
  • [28] Editorial: Risk Factors for Alzheimer's Disease
    Moreno-Gonzalez, Ines
    Morales, Rodrigo
    Baglietto-Vargas, David
    Sanchez-Varo, Raquel
    FRONTIERS IN AGING NEUROSCIENCE, 2020, 12
  • [29] Apolipoprotein E, cholesterol metabolism, diabetes, and the convergence of risk factors for Alzheimer's disease and cardiovascular disease
    I J Martins
    E Hone
    J K Foster
    S I Sünram-Lea
    A Gnjec
    S J Fuller
    D Nolan
    S E Gandy
    R N Martins
    Molecular Psychiatry, 2006, 11 : 721 - 736
  • [30] Psychosocial risk factors in Alzheimer's disease
    Kropiunigg, U
    Sebek, K
    Leonhardsberger, A
    Schemper, M
    Dal-Bianco, P
    PSYCHOTHERAPIE PSYCHOSOMATIK MEDIZINISCHE PSYCHOLOGIE, 1999, 49 (05) : 153 - +